A phase II study of erlotinib plus capecitabine (XEL) as first-line treatment for elderly patients (pts) with advanced adenocarcinoma of lung (ML 22206 study). Background: Detecting epidermal growth ...
Daraxonrasib (Rasonque), recently approved for the treatment of metastatic pancreatic cancer, is also showing promise in the ...
New research led by the Seaver Autism Center for Research and Treatment at Mount Sinai has illuminated genetic differences among children with a rare neurodevelopmental condition and could point the ...
Researchers have created the first complete map showing how hundreds of mutations in a key cancer gene affect tumor growth. By testing every possible mutation in a critical hotspot, they found that ...
Nimotuzumab plus chemotherapy versus chemotherapy alone in advanced non-small cell lung cancer: A phase II, open-label, multicenter, randomized study. This is an ASCO Meeting Abstract from the 2013 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results